RenovoRx Total Operating Expenses vs Operating Income Analysis
RNXT Stock | USD 1.21 0.02 1.68% |
RenovoRx financial indicator trend analysis is much more than just breaking down RenovoRx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RenovoRx is a good investment. Please check the relationship between RenovoRx Total Operating Expenses and its Operating Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.
Total Operating Expenses vs Operating Income
Total Operating Expenses vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RenovoRx Total Operating Expenses account and Operating Income. At this time, the significance of the direction appears to have pay attention.
The correlation between RenovoRx's Total Operating Expenses and Operating Income is -0.96. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Operating Income in the same time period over historical financial statements of RenovoRx, assuming nothing else is changed. The correlation between historical values of RenovoRx's Total Operating Expenses and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of RenovoRx are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Total Operating Expenses i.e., RenovoRx's Total Operating Expenses and Operating Income go up and down completely randomly.
Correlation Coefficient | -0.96 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Operating Income
Operating Income is the amount of profit realized from RenovoRx operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of RenovoRx is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from RenovoRx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 44.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.5 M in 2024.
2021 | 2023 | 2024 (projected) | Depreciation And Amortization | 9K | 5.4K | 5.1K | Interest Income | 57K | 111K | 64.4K |
RenovoRx fundamental ratios Correlations
Click cells to compare fundamentals
RenovoRx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.